Sareum Hldgs Plc
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical st… Read more
Sareum Hldgs Plc (SAR) - Total Liabilities
Latest total liabilities as of June 2025: £1.95 Million GBP
Based on the latest financial reports, Sareum Hldgs Plc (SAR) has total liabilities worth £1.95 Million GBP as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sareum Hldgs Plc - Total Liabilities Trend (2004–2025)
This chart illustrates how Sareum Hldgs Plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sareum Hldgs Plc Competitors by Total Liabilities
The table below lists competitors of Sareum Hldgs Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Syntek Semiconductor Co Ltd
TWO:5302
|
Taiwan | NT$565.32 Million |
|
Azimut Exploration Inc
OTCQX:AZMTF
|
USA | $7.41 Million |
|
ClearSign Combustion Corporation
NASDAQ:CLIR
|
USA | $3.67 Million |
|
First Farms A/S
CO:FFARMS
|
Denmark | Dkr784.70 Million |
|
Ceres Global Ag Corp
PINK:CERGF
|
USA | $142.01 Million |
|
Artifex Mundi SA
WAR:ART
|
Poland | zł24.63 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Sareum Hldgs Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sareum Hldgs Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sareum Hldgs Plc (2004–2025)
The table below shows the annual total liabilities of Sareum Hldgs Plc from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | £1.95 Million | +199.08% |
| 2024-06-30 | £653.00K | -24.68% |
| 2023-06-30 | £867.00K | +90.55% |
| 2022-06-30 | £455.00K | +60.12% |
| 2021-06-30 | £284.15K | +43.12% |
| 2020-06-30 | £198.54K | +35.13% |
| 2019-06-30 | £146.93K | -19.91% |
| 2018-06-30 | £183.46K | +17.95% |
| 2017-06-30 | £155.53K | +56.24% |
| 2016-06-30 | £99.55K | +47.61% |
| 2015-06-30 | £67.44K | +2.48% |
| 2014-06-30 | £65.81K | -17.66% |
| 2013-06-30 | £79.92K | -34.96% |
| 2012-06-30 | £122.87K | +26.67% |
| 2011-06-30 | £97.00K | 0.00% |
| 2010-06-30 | £97.00K | +86.54% |
| 2009-06-30 | £52.00K | -88.15% |
| 2008-06-30 | £439.00K | -62.70% |
| 2007-06-30 | £1.18 Million | +102.93% |
| 2006-06-30 | £580.00K | +22.88% |
| 2005-06-30 | £472.00K | -41.73% |
| 2004-06-30 | £810.00K | -- |